Good news for those interested in AmbAgon's screening technologies: as of this week, their new website is live! This American-Dutch medtech company, based at Twice hub Catalyst in Eindhoven and in San Francisco, discovered a new approach to drug development for metastatic breast cancer with its innovative research on stabilization of protein-protein interactions. A groundbreaking method that will shape the future of [...]
Download Catalyst brochure
